Erste Asset Management GmbH Acquires 42,456 Shares of Danaher Corporation $DHR

Erste Asset Management GmbH boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 251.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 59,369 shares of the conglomerate’s stock after acquiring an additional 42,456 shares during the quarter. Erste Asset Management GmbH’s holdings in Danaher were worth $13,702,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher during the fourth quarter valued at approximately $27,000. JPL Wealth Management LLC bought a new position in Danaher during the third quarter valued at approximately $25,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter valued at approximately $26,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in Danaher during the third quarter valued at approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DHR shares. Evercore raised their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research report on Friday, April 17th. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Finally, Barclays dropped their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $235.14.

Danaher Trading Down 0.5%

NYSE:DHR opened at $183.47 on Tuesday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market cap of $129.85 billion, a price-to-earnings ratio of 35.49, a P/E/G ratio of 2.46 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $181.19 and its 200-day moving average is $205.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the company posted $1.88 earnings per share. Equities analysts anticipate that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.